- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01225679
Late-onset Congenital Central Hypoventilation Syndrome and the Mutation of Phox2B Gene (CCHS)
Late-onset, Insidious Course and Invasive Treatment of Congenital Central Hypoventilation Syndrome in a Case With the Phox2B Mutation
Congenital central hypoventilation syndrome (CCHS) is a rare disorder of respiratory control characterized by ventilatory impairment that results in arterial hypoxemia. Although patients typically present this disease as newborns and rarely in later infancy, there have been reports of patients presenting with CCHS in adulthood.
The present study reports a unique familial case in which the father (proband) presented late-onset CCHS with an expansion mutation of the Phox2B gene that was confirmed by genetic analysis. Surprisingly, the proband did not report any manifestation of the disease during childhood, and the disease progressed following an insidious course until adulthood. At the time of diagnosis, he did not present signs of pulmonary hypertension and right-side heart failure. The patient responded well to nocturnal invasive ventilation. In contrast, his son presented CCHS as a newborn with the full complement of symptoms while his daughter did not.
The present report shows that CCHS cases characterized by a mutated Phox2 gene can progress without many symptoms and that the treatment approach used here was efficient for controlling the course of the disease. Furthermore, this case indicates that incomplete penetrance can occur. Genetic screening of family members is mandatory to evaluate the reproductive risk of the disease, especially because asymptomatic mutation carriers may be at high risk to develop the disease and transmit it to the next generation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Congenital central hypoventilation syndrome (CCHS) is a rare disorder of respiratory control characterized by ventilatory impairment that results in arterial hypoxemia. This condition worse during sleep and occurs in patients with normal mechanical properties of the lung. It is diagnosed in the absence of primary neuromuscular disease, identifiable brainstem lesions, and other sleep disturbances or substance use.
Amiel et al. (2003) identified a mutation in the Phox2B gene associated with CCHS, characterized by 5 to 9 alanine expansions within a 20-residue polyalanine region in exon 3 of the Phox2B gene. Several reports confirmed the findings of Amiel et al., supporting the view that this gene is a master switch for the development of the autonomic nervous system network linked to respiratory control. Transgenic animals carrying the human Phox2B mutation develop a similar phenotype and lack glutamatergic neurons located in the parafacial region in the brainstem, which are involved in breathing control.
Although patients typically present with CCHS as newborns and rarely in later infancy, there have been reports of patients presenting with CCHS in adulthood. In cases of late-onset CCHS, most patients report having had some symptoms since childhood, and they have parents with a history of CCHS. Symptoms of right-side heart failure are generally observed at the time of diagnosis, and nocturnal noninvasive ventilation is frequently indicated.
The present study reports a unique familial case of CCHS in which the father (proband) presented late-onset CCHS linked to a Phox2B gene expansion mutation. The presentation, course of development and treatment response for this patient was unique His son presented CCHS as a newborn, while his daughter did not.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
São Paulo, Brazil, 04024-002
- Disciplina de Medicina e Biologia do Sono, Departamento de Psicobiologia, Universidade Federal de São Paulo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:Family member
Exclusion Criteria:NA
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
polysomnography
Overnight supervised polysomnography (Embla System®) was performed in a sleep laboratory, which included capnometry.
Arterial blood gas analysis was performed by radial arterial puncture.
Ventilatory response to progressive hypercapnia was measured using the Read breathing technique.
Briefly, subjects rebreathed into an air tight 5-L bag containing a mixture of 8% carbon dioxide (CO2) and 40% oxygen (O2).
The spirometer technology used to monitor ventilation was based on a bi-directional rotating vane principle (flow sensitive).
A continuous record of CO2 concentration in the expired gas was obtained by a CO2 analyzer within the circuit.
The ventilatory hypercapnic drive was calculated from the slope produced by changes in ventilation (L.
min-1) and changes in end-tidal PCO2.
|
Vpap: 16 cm H2O inspiratory and 8 cm H2O expiratory pressures, 20 irpm. Mechanic ventilation: tidal volume of 850 ml; 16 irpm; inspiratory pressure of 40 mmHg; PEEP: 5 cm H2O.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Describe the clinical case apresentation
Time Frame: Years of evolution
|
Years of evolution
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lia Rita A Bittencourt, PhD, Universidade Federal de São Paulo/UNIFESP
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 512947
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Central Hypoventilation Syndrome
-
Assistance Publique - Hôpitaux de ParisRecruitingOndine Syndrome | Congenital Central Hypoventilation Syndrome (CCHS)France
-
National Taiwan University HospitalUnknownCentral Alveolar Hypoventilation SyndromeTaiwan
-
Association Nationale pour les Traitements A Domicile...CompletedHealthy Volunteers | Congenital Central Hypoventilation Syndrome | Patients With Nocturnal Ventilatory AssistanceFrance
-
Children's Hospital Los AngelesTerminatedCongenital Central Hypoventilation SyndromeUnited States
-
Association pour le Développement et l'Organisation...Not yet recruitingDyspnea | Congenital Central Hypoventilation Syndrome | CCHSFrance
-
Debra Weese-MayerNorthwestern University Feinberg School of Medicine; The Chicago Community...RecruitingCongenital Central Hypoventilation SyndromeUnited States
-
Debra Weese-MayerChildren's Hospital of Philadelphia; Seattle Children's Hospital; Ann & Robert... and other collaboratorsRecruitingCongenital Central Hypoventilation Syndrome | Congenital Central Hypoventilation | CCHS | CCHS With Hirschsprung Disease | CCHS With Neural Crest Tumor | CCHS With NeuroblastomaUnited States
-
University Hospital, Strasbourg, FranceTerminatedObesity-hypoventilation Syndrome | Nocturnal Alveolar HypoventilationFrance
-
Mayo ClinicRecruitingSleep Apnea Syndromes | Sleep Apnea, Obstructive | Obesity Hypoventilation Syndrome (OHS)United States
-
Great Ormond Street Hospital for Children NHS Foundation...University College, LondonCompletedNeuromuscular Diseases | Central HypoventilationUnited Kingdom
Clinical Trials on positive airway pressure, Non-invasive mechanic ventilation
-
University of Sao Paulo General HospitalUnknownMounier-Kuhn SyndromeBrazil
-
University Hospital MuensterNew Health Sciences, Inc.; Rubel GmbH, Heiligenhaus, GermanyCompletedBrain InfarctionGermany
-
Fundación para el Fomento de la Investigación Sanitaria...Completed
-
Peking University Third HospitalRecruitingMinimal Invasive Surfactant Administration in Two Different Non-invasive Ventilation Modes to NRDS InfantsChina
-
University Hospital Inselspital, BerneCompletedNoninvasive Ventilation | Hemodynamics | Heart Function Tests | Circulatory and Respiratory Physiological PhenomenaSwitzerland
-
Assistance Publique - Hôpitaux de ParisTerminatedVaso-occlusive Crisis | Sickle Cell-hemoglobin SS DiseaseFrance
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingCOVID-19 Pneumonia | Non-invasive Ventilation
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedSleep Apnea, Obstructive | Fatigue | SarcoidosisItaly
-
Columbia UniversityTerminatedMotor Neuron Disease | Amyotrophic Lateral SclerosisUnited States
-
Assiut UniversityUnknownChest--DiseasesEgypt